Intraoperative Pathological Diagnostic Innovation: Our advanced fluorescence-guided rapid detection technology utilizes near-infrared fluorescent probes targeting tumor-specific protein receptors, achieving precise tumor margin delineation through protein binding-induced fluorescence enhancement. This breakthrough enables real-time intraoperative cancer cell detection (4-minute analysis, >99% accuracy), significantly improving diagnostic precision over traditional frozen section methods, while reducing pathological workload and enhancing surgical safety through molecular-level margin assessment.